December 19, 2022 | Press Release
Boston Cell Standards Gains 510(k) Clearance for Breast Cancer Test Control Panels
The Latest News from BCS
April 27, 2026
Boston Cell Standards Enters Final Phase of FDA MDDT Program to Qualify First-in-Industry Platform to Standardize Cancer Diagnostic Assays
Continue Reading
January 20, 2026
Boston Cell Standards Calibrator technology presented at The Pathological Society of Great Britain & Ireland Winter Meeting 2026
Continue Reading
January 6, 2026
International study demonstrates the effectiveness of Boston Cell Standards Calibrators for measuring analytical sensitivity used for breast cancer diagnosis.
Continue Reading